A new clinical study published in the journal Pharmacology and by the National Institute of Health has found that cannabis is effective in treating Chrohn’s disease, which is a form of inflammatory bowel disease (IBD).
According to researchers at the Institute of Experimental and Clinical Pharmacology at the Medical University of Graz in Austria; “In ancient medicine, cannabis has been widely used to cure disturbances and inflammation of the bowel. A recent clinical study now shows that the medicinal plant Cannabis sativa has lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases.”
They continue; “In a prospective placebo-controlled study, it has been shown what has been largely anticipated from anecdotal reports, i.e. that cannabis produces significant clinical benefits in patients with Crohn’s disease. The mechanisms involved are not yet clear but most likely include peripheral actions on cannabinoid receptors 1 and 2, and may also include central actions.
The study can be found by clicking here.